Identifying proteins that influence breast cancer risk
Official title: Identification of proteins for breast cancer risk: an integrative epidemiologic and genomic study
Funded at Vanderbilt University Medical Center · NIH-10973013 · Data updated 2026-11-12
This study is looking at how certain proteins might be connected to breast cancer risk by examining genetic information from both healthy women and those with breast cancer, with the hope of finding new ways to prevent and treat the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $734,785 |
| NIH project number | 1R01CA293996-01 |
| Project ID | NIH-10973013 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include women with a family history of breast cancer or those concerned about their genetic risk factors.
✕Less likely to help
Patients who have already been diagnosed with breast cancer may not directly benefit from this research.
What this research studies
This research aims to uncover the proteins linked to breast cancer risk by analyzing genetic data from a large population. It utilizes existing samples from cancer-free women and breast cancer patients to identify target proteins that may play a role in the disease. By focusing on proteins rather than just genetic information, the study seeks to provide a clearer understanding of the biological mechanisms behind breast cancer. This approach could lead to better prevention and treatment strategies for the disease.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for predicting and preventing breast cancer.
How similar studies have gone: Previous research has successfully identified genetic factors associated with breast cancer, but this proteogenomics approach is relatively novel and untested.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Long, Jirong — Vanderbilt University Medical Center
- Study coordinator: Long, Jirong
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.